Jingwei Li

Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

Megumi Oshima, Brendon L. Neuen, Jingwei Li et al. · Journal of the American Society of Nephrology · 2020 · 163 citations · Full text

Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes

Jingwei Li, Mark Woodward, Vlado Perkovic et al. · JACC Heart Failure · 2019 · 137 citations · Full text

Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes

Jingwei Li, Bruce Neal, Vlado Perkovic et al. · Kidney International · 2020 · 126 citations · Full text

Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage

Biying Ji, Fei Zhou, Lijuan Han et al. · Translational Stroke Research · 2017 · 89 citations · Full text

Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial

Taha Sen, Jingwei Li, Brendon L. Neuen et al. · Diabetologia · 2021 · 80 citations · Full text